Edesa Biotech (EDSA) Stock Statistics & Valuation Metrics

Edesa Biotech has a market cap or net worth of $11.17M. The enterprise value is -$1.56M.

Edesa Biotech has 8,333,823 shares outstanding. The number of shares has decreased by -2.65% in one year.

Edesa Biotech’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -63.54%.

The current PE Ratio of Edesa Biotech is ―. Edesa Biotech’s PEG ratio is 0.06.

In the last 12 months, Edesa Biotech had revenue of 0.00 and earned -7.19M in profits. Earnings per share was -1.27.

In the last 12 months, operating cash flow was -7.32M and capital expenditures 3.00, giving a free cash flow of -7.32M billion.

Edesa Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

Edesa Biotech upcoming earnings date is Feb 18, 2026, After Close (Not Confirmed).

Edesa Biotech as a current ratio of 10.67, with Debt / Equity ratio of 0.00%

In the past 12 months, Edesa Biotech has paid 800.00 in taxes.

Edesa Biotech EV to EBITDA ratio is -0.46, with an EV/FCF ratio of -0.44.

Edesa Biotech has $10.79M in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.79M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Edesa Biotech is $5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy